CareDx, Inc. Amended Passive Investment Disclosure
CareDx Inc Schedules an Amendment No. 9 to a Schedule 13G/A showing 0 shares beneficially owned, representing 0% of Common Stock as of 03/13/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CareDx Inc Schedules an Amendment No. 9 to a Schedule 13G/A showing 0 shares beneficially owned, representing 0% of Common Stock as of 03/13/2026.
The filing explains an internal realignment at The Vanguard Group on 01/12/2026, after which certain Vanguard subsidiaries report holdings separately in reliance on SEC Release No. 34-39538. The filing is signed by a Vanguard officer on 03/26/2026.
Insights
Vanguard reports no beneficial ownership after organizational realignment.
The amendment states 0 shares beneficially owned and 0% of the class as of 03/13/2026, reflecting a reporting change tied to Vanguard's internal realignment on 01/12/2026.
Practical implications depend on which Vanguard subsidiaries now report separately; subsequent filings may disclose subsidiary-level positions and any trading activity affecting stake visibility.
Disclosure follows SEC Release No. 34-39538 guidance on disaggregated reporting.
The statement cites SEC Release No. 34-39538 and explains that certain subsidiaries will report separately, removing aggregated beneficial ownership from The Vanguard Group.
This is a compliance-driven amendment; any material ownership that could affect governance will appear in future separate Schedule 13 filings by those subsidiaries.
AI-generated analysis. How Rhea-AI works. Not financial advice.